CID 216239

Sorafenib

Structural Information

Molecular Formula
C21H16ClF3N4O3
SMILES
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
InChI
InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)
InChIKey
MLDQJTXFUGDVEO-UHFFFAOYSA-N
Compound name
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
9
Annotation Hits

8929
References

79360
Patents

464.0863 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 465.09358 204.2
[M+Na]+ 487.07552 211.2
[M-H]- 463.07902 209.0
[M+NH4]+ 482.12012 210.8
[M+K]+ 503.04946 204.8
[M+H-H2O]+ 447.08356 191.6
[M+HCOO]- 509.08450 218.9
[M+CH3COO]- 523.10015 237.3
[M+Na-2H]- 485.06097 206.5
[M]+ 464.08575 203.5
[M]- 464.08685 203.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe